Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis | MicrobiomeTrials← Back to trialsNCT07724847
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-04-10Est. Completion: 2027-04-10
Enrollment target: 247 participants Locations- Chinese PLA General Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Axial Spondyloarthritis (AxSpA)
GRWD0715 is an orally administered, selective inhibitor of the Endoplasmic Reticulum Aminopeptidase 1 \[ERAP1\] enzyme b…
Birtinya, AustraliaEst. completion Apr 30, 2028
Non-radiographic Axial Spondyloarthritis
The purpose of this study is to evaluate preliminary efficacy, safety pharmacokinetic (PK) characteristics, pharmacodyna…
Hefei, ChinaCompleted Mar 13, 2023